NCT01766466 - Cangrelor Ticagrelor Transition Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Coronary Artery Disease

Interventions

DRUG

cangrelor

Open-label cangrelor IV bolus (30 µg/kg), followed by an infusion of 4 µg/kg/min for two hours.

DRUG

Ticagrelor

"Ticagrelor 180mg dose: administered 0.5 h or 1.5h after the initiation of cangrelor infusion~Ticagrelor 90mg: 6 or 7 doses (depending on study arm) taken every 12 hours post cangrelor infusion."

Trial Locations (1)

05401

Fletcher Allen Health Care, Burlington